(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Purity > 99.0%(GC) Afatinib Amprenavir Fosamprenavir Image Featured Hare

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Purity > 99.0%(GC) Afatinib Amprenavir Fosamprenavir Intermediate

Tlhaloso e Khutšoanyane:

Lebitso la Lik'hemik'hale: (S) -3-Hydroxytetrahydrofuran

CAS: 86087-23-2

Colerless Transparent to Light Yellwow Liquid

Bohloeki: >99.0%(GC) Optical Purity: >99.0% (GC)

Bohareng ba Afatinib, Amprenavir, Fosamprenavir

Inquiry: alvin@ruifuchem.com

Re romelle lengolo-tsoibila

Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Phepelo ea Moetsi;Sehlahisoa se Chesang;Bohloeki bo Phahameng le Theko ea Tlholisano
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
Afatinib CAS 439081-18-2,Afatinib Dimaleate CAS 850140-73-7Tse ka Sehloohong tsa Mahareng
Amprenavir (CAS 161814-49-9) le Fosamprenavir (CAS 226700-79-4) Hare

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale	(S) -3-Hydroxytetrahydrofuran
Litlhaloso tse tšoanang	(S)-(+)-3-Hydroxytetrahydrofuran;(S) -Tetrahydrofuran-3-ol;(S)-(+)-Tetrahydro-3-Furanol
Nomoro ea CAS	86087-23-2
Nomoro ea KAtse	RF-CC101
Boemo ba Setoko	Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule	C₄H₈O₂
Boima ba Molek'hule	88.11
Ntlha e belang	80 ℃/15 mmHg(lit.)
Botenya	1.103 g/mL ho 25℃ (lit.)
Refractive Index	n20/D 1.45 (lit.)
Ho qhibiliha ha Metsi	E qhibilihang
Boemo ba ho Romela	E Rometsoe ka Tlas'a Mocheso oa Mocheso
Brand	Ruifu Chemical

Litlhaloso:

Ntho	Litlhaloso
Ponahalo	Colerless Transparent to Light Yellwow Liquid
Mokhoa oa Bohloeki / Analysis	>99.0% (GC)
Boitsebiso	Nako ea ho boloka sampole e lokela ho tsamaisana le nako ea ho bolokoa ea maemo a referense
Phetoho e khethehileng[α]_D²⁰	+17.5° ± 2.5° (C=2 ho MeOH)
Bohloeki ba Optical	ee >99.0% (GC)
Mongobo (KF)	<0.50%
(R)-(-)-3-Hydroxytetrahydrofuran	<0.15%
Tšilafalo efe kapa efe e 'Ngoe	<0.40%
Litšila kaofela	<1.00%
Tekanyetso ea Teko	Maemo a Khoebo
Tšebeliso	Bohareng ba Afatinib, Afatinib Dimaleate, Amprenavir le Amprenavir Phosphate

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 ROS

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Libarele tsa Fluoride, 25kg/Barrel, kapa ho latela tlhoko ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.

Melemo:

Bokhoni bo lekaneng: Lisebelisoa le litsebi tse lekaneng

Tšebeletso ea profeshenale: Tšebeletso e le 'ngoe ea ho reka

Sephutheloana sa OEM: Sephutheloana sa tloaelo le leibole lia fumaneha

Tlhahiso e potlakileng: Haeba e le ka har'a setoko, ho netefalitsoe hore ho tsamaisoa matsatsi a mararo

Thepa e tsitsitseng: Boloka thepa e lekaneng

Tšehetso ea Theknoloji: Tharollo ea theknoloji e teng

Tšebeletso e Tloaelehileng ea ho Kopanya: Ho tloha ho ligrama ho isa ho lik'hilograma

Boleng bo Phahameng: Ho thehile tsamaiso e felletseng ea netefatso ea boleng

LBH:

Kopo:

Shanghai Ruifu Chemical Co., Ltd. ke moetsi le mofani ea ka sehloohong oa (S)-(+)-3-Hydroxytetrahydrofuran (CAS: 86087-23-2) e nang le boleng bo phahameng, e sebelisoang haholo ha ho etsoa metsoako ea meriana le Active Pharmaceutical. Motsoako (API).(S)-(+)-3-Hydroxytetrahydrofuran ke karolo e ka sehloohong ea Afatinib (CAS 439081-18-2), Afatinib Dimaleate (CAS: 850140-73-7), Amprenavir (CAS 161814-49-9) le Fosamprenavir ( CAS 226700-79-4).Afatinib (CAS 439081-18-2) ke inhibitor e matla, e nang le covalent / e ke keng ea fetoloa, ebile e fumaneha ka molomo ka bobeli (EGFR/ErbB) receptor tyrosine kinase (RTK) inhibitor e nang le ts'ebetso ea anticancer.Afatinib (CAS 439081-18-2) ke moriana oa ngaka o ka nooang ka molomo bakeng sa phekolo ea kankere e seng e nyane ea lisele tsa matšoafo (NSCLC) ka li-atypical Epidermal Growth Factor Receptor (EFGR) agents.Amprenavir (CAS 161814-49-9) ke HIV protease inhibitor e sebelisoang ho phekola tšoaetso ea HIV.Amprenavir hape ke SARS-CoV 3CLpro inhibitor e nang le IC50 ea 1.09 μM.Fosamprenavir (Amprenavir phosphate;GW 433908) ke phosphate ester prodrug ea antiretroviral protease inhibitor Amprenavi.